Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2016. The report addresses the status of a Special Meeting of Shareholders and Special Meetings of Series 10, 11, and 12 Warrant Holders originally convened on December 8, 2016.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meetings and does not contain financial statements.
Material Changes
The primary material event reported is the adjournment of the Special Meetings of Shareholders and Warrant Holders due to a lack of quorum on December 8, 2016. No financial material changes are disclosed in this text.
Outlook, Risks, and Management Commentary
Management has reconvened the meetings for Thursday, December 15, 2016, at the Company's offices in Petach Tikva, Israel. The specific times for the reconvened meetings are:
- Special Meeting of Shareholders: 4:00 p.m. (Israel time)
- Special Meeting of Series 10 Warrant Holders: 4:30 p.m. (Israel time)
- Special Meeting of Series 11 Warrant Holders: 4:45 p.m. (Israel time)
- Special Meeting of Series 12 Warrant Holders: 5:00 p.m. (Israel time)
The filing notes that this report is incorporated by reference into the registrant's Registration Statements on Form F-3.
Key Facts for Investor Verification
- Verify the outcome of the reconvened meetings scheduled for December 15, 2016.
- Confirm the specific proposals being voted on by shareholders and warrant holders, as the text does not detail the agenda items.
- Check subsequent filings for any financial updates or results stemming from the shareholder meetings.